Qualitative insights into general practitioners views on polypharmacy

Sibyl Anthierens, Anneleen Tansens, Mirko Petrovic, Thierry Christiaens, Sibyl Anthierens, Anneleen Tansens, Mirko Petrovic, Thierry Christiaens

Abstract

Background: Polypharmacy is common among older people. The purpose of this study is to describe GPs' views and beliefs on polypharmacy in order to identify the role of the GP in relation to improving prescribing behaviour. The awareness of these often established beliefs is key for understanding behaviour and promoting change which can guide action towards more rational prescribing.

Methods: A qualitative descriptive methodology was used with semi-structured interviews. Interviews were conducted with 65 GPs from the region of Aalst, a district of a mixed urban and rural population in Belgium. The aim of the study was to describe the GPs' perspectives on polypharmacy in primary care.

Results: GPs acknowledge that polypharmacy is a problem in their older patient population, especially because of the risk of adverse drug reactions, interactions and lowered adherence. GPs mention that difficulties in keeping an overview of the exact medication intake is an important problem caused by polypharmacy. The patients' strong belief in their medication and self-medication are seen as important barriers in reducing the number of drugs taken. Next to these patient related factors, there are some factors related to the prescriber, such as the lack of regular evaluation of the medication schedule by GPs and the involvement of several prescribers, especially in a hospital setting. According to the respondents, prevention and evidence based medicine guidelines often induce polypharmacy.

Conclusions: GPs point out that polypharmacy is an important problem in their older patient population. They see an important role for themselves in optimizing drug regimens for their patients. However, they do not have a readymade solution for polypharmacy. The limited set of options for addressing polypharmacy leave GPs feeling powerless to tackle the problem. There is a need for simple GP friendly tools and access to pharmacotherapeutic advice. Future research in this area and interventions seeking to improve prescribing for the elderly will have to focus on practical tools and take into account the GPs' sense of helplessness.

References

    1. Aronson JK, Henderson G, Webb DJ, Rawlings MD. A prescription for better prescribing. BMJ. 2006;333:459–460. doi: 10.1136/.
    1. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol. 1991;44:1353–1359. doi: 10.1016/0895-4356(91)90096-R.
    1. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systemic review of the role of the pharmacist. Drugs Aging. 2003;20:817–32. doi: 10.2165/00002512-200320110-00003.
    1. Veehof LJG, Stewart RE, Haaijer-Ruskamp FM, Meyboom-de Jong B. The development of polypharmacie. A longitudinal study. Family Practice. 2000;17(3):261–267. doi: 10.1093/fampra/17.3.261.
    1. Beijler H, Blaey CD. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54. doi: 10.1023/A:1015570104121.
    1. Heath I. Never had it so good? Multiple health problems in elderly people. BMJ. 2008;336:950–951. doi: 10.1136/bmj.39532.671319.94.
    1. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336:606–609. doi: 10.1136/bmj.39503.424653.80.
    1. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med. 2004;164:305–312. doi: 10.1001/archinte.164.3.305.
    1. Fields TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Ecler M, Benser M, Bates DW. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–1634. doi: 10.1001/archinte.161.13.1629.
    1. Moreira T. Sleep, health and the dynamics of biomedicine. Social Science and Medicine. 2006;63(1):54–63. doi: 10.1016/j.socscimed.2005.11.066.
    1. Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334–40. doi: 10.1002/1098-240X(200008)23:4<334::AID-NUR9>;2-G.
    1. Patton MQ. Qualitative Evaluation of research methods. Newbury Park California; 1990. Sage.
    1. Sandelowski M. Sample size in qualitative research. Research in Nursing & Health. 1995;18:179–183.
    1. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Education Today. 2004;24:105–12. doi: 10.1016/j.nedt.2003.10.001.
    1. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qualitative Health research. 2005;15(9):1277–1288. doi: 10.1177/1049732305276687.
    1. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of medicine. 1996. pp. 428–437.
    1. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients. Arch Intern Med. 2002;162:1670–3. doi: 10.1001/archinte.162.15.1670.
    1. Gottlieb S. Inappropriate drug prescribing in elderly people is common. BMJ. 2004;329(7462):367. doi: 10.1136/bmj.329.7462.367.
    1. Ryan C, O'Mahony D, Kennedy J, Weedle P, Barry P, Gallagher P, Byrne S. Appropriate prescribing in the elderly: an inverstigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland. Journal of Clinical Pharmacy and Therapeutics. 2009;34:369–376. doi: 10.1111/j.1365-2710.2008.01007.x.
    1. Mark H, Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Int Med. 1997;157(14):1531–6. doi: 10.1001/archinte.157.14.1531. An update.
    1. Lewis TL. Medication Review for the 10-Minute Consultation: The NO TEARS Tool. Geriatric Aging. 2005;8(6):43–45.
    1. Wenger NS, Shekelle PG. ACOVE Investigators. Assessing Care of Vulnerable Elders: ACOVE Project Overview. Ann Intern Med. 2001;135:642–646.
    1. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimized? The Lancet. 2007;370:173–87. doi: 10.1016/S0140-6736(07)61091-5.
    1. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Review. Arch Intern Med. 2004;164(18):1957–9. doi: 10.1001/archinte.164.18.1957.
    1. Jackson SH, Mangoni AA, Batty GM. Optimization of drug prescribing. Review. Br J Clin Pharmacol. 2004;57(3):231–6. doi: 10.1046/j.1365-2125.2003.02018.x.
    1. Larson EB. General internal medicine at the crossroads of prosperity and despair: caring for patients with chronic diseases in an ageing society. Ann Intern Med. 2001;134:997–1000.
    1. Straand J, Fetveit A, Rognstad S, Gjelstad S, Brekke M, Dalen I. A cluster-randomized educational intervention to reduce inappropriate prescription patterns for elderly patients in general practice - The prescription peer academic detailing (Rx-PAD) study. BMC Health Services Research. 2006. pp. 72–82.
    1. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24:14–19. doi: 10.1093/fampra/cml067.
    1. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5:31–9. doi: 10.1016/j.amjopharm.2007.03.004.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner